• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Statins and COVID-19: To Suspend or Not to Suspend? That is the Question!

作者信息

Ferrari Filipe, Santos Raul D

机构信息

Programa de Pós-Graduação em Cardiologia e Ciências Cardiovasculares, Universidade Federal do Rio Grande do Sul, Hospital de Clínicas de Porto Alegre, Porto Alegre, RS - Brasil.

Unidade Clínica de Lípides, Instituto do Coração (InCor), Hospital da Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP - Brasil.

出版信息

Arq Bras Cardiol. 2021 Jan;116(1):147-152. doi: 10.36660/abc.20200949.

DOI:10.36660/abc.20200949
PMID:33566980
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8159509/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94f1/8159509/c796a88d7a39/0066-782X-abc-116-01-0147-gf01-en.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94f1/8159509/67c469a2c4a2/0066-782X-abc-116-01-0147-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94f1/8159509/c796a88d7a39/0066-782X-abc-116-01-0147-gf01-en.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94f1/8159509/67c469a2c4a2/0066-782X-abc-116-01-0147-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94f1/8159509/c796a88d7a39/0066-782X-abc-116-01-0147-gf01-en.jpg

相似文献

1
Statins and COVID-19: To Suspend or Not to Suspend? That is the Question!他汀类药物与新冠病毒病：停用还是不停用？这是个问题！
Arq Bras Cardiol. 2021 Jan;116(1):147-152. doi: 10.36660/abc.20200949.
2
Letter by Carmona et al Regarding Article, "Beneficial Effect of Statins in COVID-19-Related Outcomes-Brief Report: a National Population-Based Cohort Study".卡尔莫纳等人就文章《他汀类药物对COVID-19相关结局的有益影响——简要报告：一项基于全国人群的队列研究》所写的信。
Arterioscler Thromb Vasc Biol. 2021 May 5;41(5):e280-e281. doi: 10.1161/ATVBAHA.121.316224. Epub 2021 Apr 21.
3
Increased mortality risk associated with statins in the CORONADO study.在CORONADO研究中，他汀类药物与死亡风险增加相关。
Diabetes Metab. 2021 May;47(3):101250. doi: 10.1016/j.diabet.2021.101250. Epub 2021 Mar 17.
4
Impact of statins in patients with COVID-19.他汀类药物对新冠病毒疾病患者的影响。
Rev Esp Cardiol (Engl Ed). 2021 Jul;74(7):637-640. doi: 10.1016/j.rec.2021.01.005. Epub 2021 Jan 21.
5
More Good News on Statins and COVID-19.关于他汀类药物与新冠病毒的更多好消息。
Am J Cardiol. 2021 Jan 1;138:127-128. doi: 10.1016/j.amjcard.2020.10.026. Epub 2020 Oct 23.
6
Should statins be considered for the management of mucormycosis in COVID-19?在新冠病毒感染（COVID-19）中，是否应考虑使用他汀类药物来治疗毛霉菌病？
Diabetes Metab Syndr. 2021 Jul-Aug;15(4):102162. doi: 10.1016/j.dsx.2021.05.035. Epub 2021 Jun 5.
7
Anticoagulation, Statins and "Arterial Thrombotic Sequalae after Covid-19: Mind the Gap".抗凝治疗、他汀类药物与“新冠病毒感染后动脉血栓形成后遗症：注意差距”
Ann Vasc Surg. 2021 Nov;77:e5-e6. doi: 10.1016/j.avsg.2021.05.025. Epub 2021 Aug 17.
8
Authors' response: Meta-analysis of statin and outcomes of coronavirus disease 2019 (COVID-19).作者回应：他汀类药物与2019冠状病毒病（COVID-19）结局的荟萃分析。
Nutr Metab Cardiovasc Dis. 2021 Aug 26;31(9):2740-2742. doi: 10.1016/j.numecd.2021.06.008. Epub 2021 Jun 29.
9
Use of statins in patients with COVID-19.他汀类药物在新冠肺炎患者中的应用。
QJM. 2020 Aug 1;113(8):604-605. doi: 10.1093/qjmed/hcaa172.
10
Response to: Use of statins in patients with COVID-19.回应：新冠病毒疾病患者使用他汀类药物的情况
QJM. 2020 Aug 1;113(8):606-607. doi: 10.1093/qjmed/hcaa173.

引用本文的文献

1
COVID-19: Direct and Indirect Mechanisms of Statins.COVID-19：他汀类药物的直接和间接作用机制。
Int J Mol Sci. 2021 Apr 17;22(8):4177. doi: 10.3390/ijms22084177.
2
Lipid homeostasis and mevalonate pathway in COVID-19: Basic concepts and potential therapeutic targets.新型冠状病毒肺炎中的脂质稳态和甲羟戊酸途径：基本概念和潜在治疗靶点。
Prog Lipid Res. 2021 Apr;82:101099. doi: 10.1016/j.plipres.2021.101099. Epub 2021 Apr 26.

本文引用的文献

1
Statin Use Is Associated with Decreased Risk of Invasive Mechanical Ventilation in COVID-19 Patients: A Preliminary Study.他汀类药物的使用与新冠病毒肺炎患者有创机械通气风险降低相关：一项初步研究。
Pathogens. 2020 Sep 17;9(9):759. doi: 10.3390/pathogens9090759.
2
Relation of Statin Use Prior to Admission to Severity and Recovery Among COVID-19 Inpatients.住院前使用他汀类药物与 COVID-19 住院患者严重程度和恢复的关系。
Am J Cardiol. 2020 Dec 1;136:149-155. doi: 10.1016/j.amjcard.2020.09.012. Epub 2020 Sep 16.
3
Pros and cons for use of statins in people with coronavirus disease-19 (COVID-19).
在2019冠状病毒病（COVID-19）患者中使用他汀类药物的利弊。
Diabetes Metab Syndr. 2020 Sep-Oct;14(5):1225-1229. doi: 10.1016/j.dsx.2020.07.011. Epub 2020 Jul 11.
4
The Effects of ARBs, ACEis, and Statins on Clinical Outcomes of COVID-19 Infection Among Nursing Home Residents.血管紧张素受体阻滞剂（ARBs）、血管紧张素转换酶抑制剂（ACEis）和他汀类药物对养老院居民 COVID-19 感染临床结局的影响。
J Am Med Dir Assoc. 2020 Jul;21(7):909-914.e2. doi: 10.1016/j.jamda.2020.06.018. Epub 2020 Jun 15.
5
Atorvastatin associated with decreased hazard for death in COVID-19 patients admitted to an ICU: a retrospective cohort study.阿托伐他汀与入住重症监护病房的COVID-19患者死亡风险降低相关：一项回顾性队列研究。
Crit Care. 2020 Jul 14;24(1):429. doi: 10.1186/s13054-020-03154-4.
6
In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19.住院期间使用他汀类药物与 COVID-19 患者的死亡率降低相关。
Cell Metab. 2020 Aug 4;32(2):176-187.e4. doi: 10.1016/j.cmet.2020.06.015. Epub 2020 Jun 24.
7
Venous thromboembolism and COVID-19.静脉血栓栓塞与2019冠状病毒病
Respir Med Res. 2020 Nov;78:100759. doi: 10.1016/j.resmer.2020.100759. Epub 2020 Apr 28.
8
Hypolipidemia is associated with the severity of COVID-19.血脂异常与 COVID-19 的严重程度有关。
J Clin Lipidol. 2020 May-Jun;14(3):297-304. doi: 10.1016/j.jacl.2020.04.008. Epub 2020 Apr 30.
9
High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study.严重严重急性呼吸综合征冠状病毒 2 型感染患者的血栓形成风险高：一项多中心前瞻性队列研究。
Intensive Care Med. 2020 Jun;46(6):1089-1098. doi: 10.1007/s00134-020-06062-x. Epub 2020 May 4.
10
Letter to the Editor: Low-density lipoprotein is a potential predictor of poor prognosis in patients with coronavirus disease 2019.给编辑的信：低密度脂蛋白是预测 2019 冠状病毒病患者预后不良的一个潜在指标。
Metabolism. 2020 Jun;107:154243. doi: 10.1016/j.metabol.2020.154243. Epub 2020 Apr 19.